BartoTL, FlumePA. 2010. Treatment of pulmonary exacerbations in adult cystic fibrosis patients: a review. Hosp Pract, 38(1):26–34.
2.
BrusciaEM, ZhangP-X, SatohA, CaputoC, MedzhitovR, ShenoyA, EganME, KrauseDS. 2011. Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis. J Immunol (Baltimore, MD: 1950), 186(12):6990–6998.
3.
CasilagF, LorenzA, KruegerJ, KlawonnF, WeissS, HäusslerS. 2016. The LasB Elastase of Pseudomonas aeruginosa acts in concert with alkaline protease AprA to prevent flagellin-mediated immune recognition. Infect Immun, 84(1):162–171.
4.
ChattorajSS, GanesanS, FarisA, ComstockA, LeeW-M, SajjanUS. 2011. Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells. Infect Immun, 79(10):4131–4145.
5.
ChenJ, WangD, SunZ, GaoL, ZhuX, GuoJ, XuS, FangL, LiK, XiaoS. 2019. Arterivirus nsp4 antagonizes interferon beta production by proteolytically cleaving NEMO at multiple sites. J Virol, 93(12):e00385-19.
6.
DiMangoE, ZarHJ, BryanR, PrinceA. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest, 96(5):2204–2210.
7.
KharazmiA. 1991. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. Immunol Lett, 30(2):201–205.
8.
LaarmanAJ, BardoelBW, RuykenM, FernieJ, MilderFJ, van StrijpJA, RooijakkersSH. 2012. Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways. J Immunol, 188(1):386–393.
NguyenD, SinghPK. 2006. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci U S A, 103(22):8305–8306.
11.
OwenKA, AndersonCJ, CasanovaJE. 2016. Salmonella suppresses the TRIF-dependent type i interferon response in macrophages. mBio, 7(1):e02051-15.
12.
ParkerD, CohenTS, AlhedeM, HarfenistBS, MartinFJ, PrinceA. 2012. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol, 46(1):6–13.
13.
PellizzariR, Guidi-RontaniC, VitaleG, MockM, MontecuccoC. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ-induced release of NO and TNFα. FEBS Lett, 462(1–2):199–204.
SherrardLJ, TunneyMM, ElbornJS. 2014. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis. Lancet, 384(9944):703–713.
16.
SörensenM, KantorekJ, ByrnesL, BoutinS, MallMA, LasitschkaF, ZabeckH, NguyenD, DalpkeAH. 2020. Pseudomonas aeruginosa modulates the antiviral response of bronchial epithelial cells. Front Immunol, 11:96.
17.
SyedbashaM, EgliA. 2017. Interferon lambda: modulating immunity in infectious diseases. Front Immunol 8(119);, DOI: 10.3389/fimmu.2017.00119.
18.
WangBX, FishEN. 2017. Interactions between NS1 of influenza A viruses and interferon-α/β: determinants for vaccine development. J Interferon Cytokine Res, 37(8):331–341.
19.
ZhangQ, KeH, BlikslagerA, FujitaT, YooD. 2018. Type III interferon restriction by porcine epidemic diarrhea virus and the role of viral protein nsp1 in IRF1 signaling. J Virol, 92(4):e01677-17.
